Ventyx biosciences to participate in the barclays global healthcare conference

Encinitas, calif., march 07, 2022 (globe newswire) -- ventyx biosciences, inc. (nasdaq: vtyx) (“ventyx” or the “company”), a clinical-stage biopharmaceutical company focused on advancing new therapies for millions of patients living with inflammatory diseases and autoimmune disorders, announced today that raju mohan, chief executive officer of ventyx, will provide a company overview at the barclays global healthcare conference being held march 15-17, 2022.
VTYX Ratings Summary
VTYX Quant Ranking